v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flow from operating activities:    
Net loss $ (130,516) $ (154,719)
Adjustments to reconcile net loss to cash used in operations:    
Depreciation and amortization 45,238 45,844
Deferred income tax expense 62 40,782
Non-cash stock-based compensation expense 4,146 3,434
Non-cash interest expense 5,843 5,844
Lower of cost or market inventory valuation adjustment 9,792 6,326
Restructuring Costs and Asset Impairment Charges 12,317 0
Gain (Loss) on Disposition of Other Assets (12,777) 0
Changes in assets and liabilities:    
Accounts receivable, net (4,877) 9,142
Inventories (31,294) (15,034)
Prepaid and other current assets (9,301) (6,263)
Income taxes payable (1,526) (691)
Accounts payable and other accruals 8,855 (17,762)
Interest payable 18,840 16,816
Change in Tax Receivable Agreement 0 (5,824)
Other (6,793) 11,383
Net cash used in operating activities (91,991) (60,722)
Cash flow from investing activities:    
Capital expenditures (26,856) (20,514)
Proceeds from the sale of fixed assets 9,882 298
Net cash used in investing activities (16,974) (20,216)
Cash flow from financing activities:    
Proceeds from Delayed Draw First Lien Term Loan due 2029 100,000 0
Proceeds from issuance of common stock, net of issuance costs 5,073 0
Payments for taxes related to net share settlement of equity awards (350) (230)
Principal payments under finance lease obligations (106) (80)
Net cash provided by (used in) financing activities 104,617 (310)
Net change in cash and cash equivalents (4,348) (81,248)
Effect of exchange rate changes on cash and cash equivalents 233 2,635
Cash and cash equivalents at beginning of period 138,427 256,248
Cash and cash equivalents at end of period 134,312 177,635
Net cash paid during the periods for:    
Interest 49,798 57,117
Income taxes 5,857 4,394
Change in capital expenditures in accounts payable $ (4,406) $ (5,506)